Novo Nordisk Foundation Tightens Grip on Boardroom Power as Governance Battle Reshapes Corporate Direction
Novo Nordisk’s extraordinary shareholder meeting marked one of the most consequential governance shifts in modern European corporate history, as the Novo Nordisk Foundation consolidated near-total boardroom control of the world’s most valuable pharmaceutical company by market capitalization. The Foundation’s success in restructuring the board and installing its own leadership reflects deep strategic concerns over the…









